NO164099C - Analogifremgangsmaate for fremstilling av terapeutisk aktivt 2-klornicergolin og syreaddisjonssalter derav. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktivt 2-klornicergolin og syreaddisjonssalter derav.

Info

Publication number
NO164099C
NO164099C NO862493A NO862493A NO164099C NO 164099 C NO164099 C NO 164099C NO 862493 A NO862493 A NO 862493A NO 862493 A NO862493 A NO 862493A NO 164099 C NO164099 C NO 164099C
Authority
NO
Norway
Prior art keywords
chlornicergolin
preparation
acid addition
addition salts
therapeutic active
Prior art date
Application number
NO862493A
Other languages
English (en)
Norwegian (no)
Other versions
NO862493L (no
NO164099B (no
NO862493D0 (no
Inventor
Gabor Megyeri
Tibor Keve
Bela Stefko
Erik Bogsch
Janos Galambos
Anna Kassai
Ferenc Trischler
Eva Palosi
Dora Groo
Egon Karpati
Zsolt Szombathelyi
Laszlo Szporny
Bela Kiss
Istvan Laszlovsky
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO862493D0 publication Critical patent/NO862493D0/no
Publication of NO862493L publication Critical patent/NO862493L/no
Publication of NO164099B publication Critical patent/NO164099B/no
Publication of NO164099C publication Critical patent/NO164099C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO862493A 1985-06-21 1986-06-20 Analogifremgangsmaate for fremstilling av terapeutisk aktivt 2-klornicergolin og syreaddisjonssalter derav. NO164099C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU852447A HU193782B (en) 1985-06-21 1985-06-21 Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof

Publications (4)

Publication Number Publication Date
NO862493D0 NO862493D0 (no) 1986-06-20
NO862493L NO862493L (no) 1986-12-22
NO164099B NO164099B (no) 1990-05-21
NO164099C true NO164099C (no) 1990-08-29

Family

ID=10959403

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862493A NO164099C (no) 1985-06-21 1986-06-20 Analogifremgangsmaate for fremstilling av terapeutisk aktivt 2-klornicergolin og syreaddisjonssalter derav.

Country Status (30)

Country Link
US (1) US4753949A (es)
JP (1) JPS62485A (es)
CN (1) CN1015365B (es)
AR (1) AR241533A1 (es)
AT (1) AT390614B (es)
AU (1) AU594686B2 (es)
BE (1) BE904957A (es)
CH (1) CH671018A5 (es)
CS (1) CS255875B1 (es)
DD (1) DD246111A5 (es)
DE (1) DE3620647A1 (es)
DK (1) DK292086A (es)
ES (1) ES8800953A1 (es)
FI (1) FI84605C (es)
FR (1) FR2583756B1 (es)
GB (1) GB2176788B (es)
HU (1) HU193782B (es)
IL (1) IL79179A0 (es)
IN (1) IN163116B (es)
IT (1) IT1204865B (es)
LU (1) LU86485A1 (es)
NL (1) NL8601612A (es)
NO (1) NO164099C (es)
PH (1) PH24732A (es)
PL (1) PL147390B1 (es)
PT (1) PT82808B (es)
SE (1) SE463716B (es)
SU (1) SU1445557A3 (es)
YU (1) YU107986A (es)
ZA (1) ZA864633B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193781B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 10alpha-methoxy-6-methylergoline derivatives and acid additional salts thereof
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3228943A (en) * 1962-06-11 1966-01-11 Lumilysergol derivatives
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
GB1513322A (en) * 1976-01-09 1978-06-07 Farmaceutici Italia Heterocyclic ergoline derivatives
YU39278B (en) * 1976-12-22 1984-10-31 Lek Tovarna Farmacevtskih Process for preparing 5-bromo nicotinic acid esters
IT1094965B (it) * 1978-04-05 1985-08-10 Corvi Mora E Procedimento di preparazione di derivati del lisergolo
EP0091652B1 (en) * 1982-04-13 1986-02-26 FARMITALIA CARLO ERBA S.p.A. Ergoline derivatives, process for producing the ergoline derivatives and pharmaceutical compositions containing them
CH649998A5 (de) * 1982-08-09 1985-06-28 Sandoz Ag Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
GB8612366D0 (en) * 1986-05-21 1986-06-25 Erba Farmitalia Ergoline esters
GB8615471D0 (en) * 1986-06-25 1986-07-30 Erba Farmitalia T-butyl ergoline derivatives

Also Published As

Publication number Publication date
ATA168486A (de) 1989-11-15
GB2176788A (en) 1987-01-07
PH24732A (en) 1990-10-01
PT82808B (pt) 1988-04-21
FR2583756B1 (fr) 1990-01-12
CN1015365B (zh) 1992-02-05
DD246111A5 (de) 1987-05-27
US4753949A (en) 1988-06-28
AR241533A1 (es) 1992-08-31
DK292086D0 (da) 1986-06-20
ES8800953A1 (es) 1987-12-16
SE463716B (sv) 1991-01-14
LU86485A1 (de) 1986-12-02
PL147390B1 (en) 1989-05-31
NO862493L (no) 1986-12-22
SU1445557A3 (ru) 1988-12-15
DK292086A (da) 1986-12-22
AT390614B (de) 1990-06-11
BE904957A (fr) 1986-12-19
SE8602737L (sv) 1986-12-22
HU193782B (en) 1987-11-30
FI862635A (fi) 1986-12-22
IL79179A0 (en) 1986-09-30
IT1204865B (it) 1989-03-10
GB8615120D0 (en) 1986-07-23
DE3620647A1 (de) 1987-01-02
FI84605B (fi) 1991-09-13
JPH0529227B2 (es) 1993-04-28
FR2583756A1 (fr) 1986-12-26
NO164099B (no) 1990-05-21
IT8620873A0 (it) 1986-06-20
FI84605C (fi) 1991-12-27
HUT41024A (en) 1987-03-30
CH671018A5 (es) 1989-07-31
GB2176788B (en) 1989-07-26
ZA864633B (en) 1987-02-25
JPS62485A (ja) 1987-01-06
CS255875B1 (en) 1988-03-15
SE8602737D0 (sv) 1986-06-19
AU5891686A (en) 1986-12-24
NL8601612A (nl) 1987-01-16
IN163116B (es) 1988-08-13
PT82808A (en) 1986-07-01
ES556359A0 (es) 1987-12-16
FI862635A0 (fi) 1986-06-19
NO862493D0 (no) 1986-06-20
YU107986A (en) 1988-04-30
CN86104086A (zh) 1986-12-17
AU594686B2 (en) 1990-03-15

Similar Documents

Publication Publication Date Title
NO170480C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO864425L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyl-oksoftalazinyl-eddiksyre-derivater
NO172343C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive askorbinsyrederivater
NO865204L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzosyre- og benzosyreester-derivater.
NO165023C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol- og furan derivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO871295D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO167916C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO167660C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylmetylazoler og salter derav.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO870049L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO162619C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive l-aminosyre-derivater
NO863373L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO172051C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyreesterderivater og deglukoteicoplanin
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO891114L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO171108C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater
NO164895C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO164099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 2-klornicergolin og syreaddisjonssalter derav.